Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Chemoradiotherapy (CRT) & Levilactobacillus brevis

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Levilactobacillus brevis CD2 lozenges reduced the incidence of grade III and IV anticancer therapy-induced Mucositis (oral) and were associated with a lower overall rate of mucositis and a higher rate of anticancer treatment completion.
Sharma et al. 2012 Eur J Cancer 48(6): 875–881

…

References (Sources)

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
Sharma et al. 2012 Eur J Cancer 48(6): 875–881.

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Chemoradiotherapy (CRT) & Levilactobacillus brevis

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat